JUNE 12, 2026 AT 04:42 PM

Merck (MRK) FDA approves Belzutifan/Keytruda combination treatment for kidney cancer

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#GERMANY#EUROPE#MERCK & CO INC#MRK.US#MERCK KGAA#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DAX 40 INDEX#MRK#US EQUITIES